Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer

NCT05722327 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer
Colorectal Cancer

Interventions

DRUG: MRTX849
DRUG: Irinotecan
DRUG: Cetuximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]